High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes

Experimental Cell Research

Volumn 339, Issue 2, 2015, Pages 280-288

  Dijksterhuis, Jacomijn P ^a   Arthofer, Elisa ^a   Marinescu, Voichita D ^b   Nelander, Sven ^b   Uhlén, Mathias ^c   Pontén, Frederik ^b   Mulder, Jan ^a   Schulte, Gunnar ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^d MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Glioma; Major histocompatibility complex II; Microglia; Tumor microenvironment; WNT 5A

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; WNT5A PROTEIN; ONCOPROTEIN; WNT PROTEIN; WNT5A PROTEIN, HUMAN;

ARTICLE; BRAIN TISSUE; CANCER GENETICS; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MALE; MICROGLIA; MONOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE MICROARRAY; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; UPREGULATION; BIOLOGY; BIOSYNTHESIS; GENETICS; METABOLISM; PATHOLOGY;

COMPUTATIONAL BIOLOGY; FEMALE; GLIOMA; HUMANS; MALE; MICROGLIA; MONOCYTES; PROTO-ONCOGENE PROTEINS; TISSUE ARRAY ANALYSIS; WNT PROTEINS;

EID: 84973408245     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.10.022     Document Type: Article

References (56)

1. [1] Schulte, G., International Union of Basic and Clinical Pharmacology. LXXX. The class Frizzled receptors. Pharmacol. Rev. 62 (2010), 632–667.
2. [2] Kikuchi, A., Yamamoto, H., Sato, A., Matsumoto, S., Wnt5a: its signalling, functions and implication in diseases. Acta Physiol. 204 (2012), 17–33.
3. [3] Clevers, H., Nusse, R., Wnt/beta-catenin signaling and disease. Cell 149 (2012), 1192–1205.
4. [4] van Amerongen, R., Nusse, R., Towards an integrated view of Wnt signaling in development. Development 136 (2009), 3205–3214.
5. [5] Kremenevskaja, N., von Wasielewski, R., Rao, A.S., Schofl, C., Andersson, T., Brabant, G., Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24 (2005), 2144–2154.
6. [6] Jonsson, M., Dejmek, J., Bendahl, P.O., Andersson, T., Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res. 62 (2002), 409–416.
7. [7] Kurayoshi, M., Oue, N., Yamamoto, H., Kishida, M., Inoue, A., Asahara, T., Yasui, W., Kikuchi, A., Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res. 66 (2006), 10439–10448.
8. [8] Lewis, T.B., Robison, J.E., Bastien, R., Milash, B., Boucher, K., Samlowski, W.E., Leachman, S.A., Dirk Noyes, R., Wittwer, C.T., Perreard, L., Bernard, P.S., Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction. Cancer 104 (2005), 1678–1686.
9. [9] Ohgaki, H., Kleihues, P., Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol. 64 (2005), 479–489.
10. [10] Charles, N.A., Holland, E.C., Gilbertson, R., Glass, R., Kettenmann, H., The brain tumor microenvironment. Glia 59 (2011), 1169–1180.
11. [11] Kamino, M., Kishida, M., Kibe, T., Ikoma, K., Iijima, M., Hirano, H., Tokudome, M., Chen, L., Koriyama, C., Yamada, K., Arita, K., Kishida, S., Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci. 102 (2011), 540–548.
12. [12] Yu, J.M., Jun, E.S., Jung, J.S., Suh, S.Y., Han, J.Y., Kim, J.Y., Kim, K.W., Jung, J.S., Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett. 257 (2007), 172–181.
13. [13] Halleskog, C., Dijksterhuis, J.P., Kilander, M.B., Becerril-Ortega, J., Villaescusa, J.C., Lindgren, E., Arenas, E., Schulte, G., Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation. J. Neuroinflammation, 9, 2012, 111.
14. [14] Markovic, D.S., Glass, R., Synowitz, M., Rooijen, N., Kettenmann, H., Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 64 (2005), 754–762.
15. [15] Holtkamp, N., Afanasieva, A., Elstner, A., van Landeghem, F.K., Konneker, M., Kuhn, S.A., Kettenmann, H., von Deimling, A., Brain slice invasion model reveals genes differentially regulated in glioma invasion. Biochem. Biophys. Res. Commun. 336 (2005), 1227–1233.
16. [16] Yi, L., Xiao, H., Xu, M., Ye, X., Hu, J., Li, F., Li, M., Luo, C., Yu, S., Bian, X., Feng, H., Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. J. Neuroimmunol. 232 (2011), 75–82.
17. [17] Hu, F., Dzaye, O.D. a, Hahn, A., Yu, Y., Scavetta, R.J., Dittmar, G., Kaczmarek, A.K., Dunning, K.R., Ricciardelli, C., Rinnenthal, J.L., Heppner, F.L., Lehnardt, S., Synowitz, M., Wolf, S.A., Kettenmann, H., Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signaling. Neuro-Oncology 17 (2015), 200–210.
18. [18] Ellert-Miklaszewska, A., Dabrowski, M., Lipko, M., Sliwa, M., Maleszewska, M., Kaminska, B., Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Glia 61 (2013), 1178–1190.
19. [19] Pukrop, T., Klemm, F., Hagemann, T., Gradl, D., Schulz, M., Siemes, S., Trumper, L., Binder, C., Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc. Natl. Acad. Sci. USA 103 (2006), 5454–5459.
20. [20] Pukrop, T., Dehghani, F., Chuang, H.N., Lohaus, R., Bayanga, K., Heermann, S., Regen, T., Van Rossum, D., Klemm, F., Schulz, M., Siam, L., Hoffmann, A., Trumper, L., Stadelmann, C., Bechmann, I., Hanisch, U.K., Binder, C., Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia 58 (2010), 1477–1489.
21. [21] Uhlen, M., Fagerberg, L., Hallstrom, B.M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, A., Kampf, C., Sjostedt, E., Asplund, A., Olsson, I., Edlund, K., Lundberg, E., Navani, S., Szigyarto, C.A., Odeberg, J., Djureinovic, D., Takanen, J.O., Hober, S., Alm, T., Edqvist, P.H., Berling, H., Tegel, H., Mulder, J., Rockberg, J., Nilsson, P., Schwenk, J.M., Hamsten, M., von Feilitzen, K., Forsberg, M., Persson, L., Johansson, F., Zwahlen, M., von Heijne, G., Nielsen, J., Ponten, F., Proteomics. Tissue-based map of the human proteome. Science, 347, 2015, 1260419.
22. [22] Kampf, C., Olsson, I., Ryberg, U., Sjostedt, E., Ponten, F., Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas. J. Vis. Exp., 31, 2012, 3620 10.3791/3620.
23. [23] Gao, J., Ade, A.S., Tarcea, V.G., Weymouth, T.E., Mirel, B.R., Jagadish, H.V., States, D.J., Integrating and annotating the interactome using the MiMI plugin for cytoscape. Bioinformatics 25 (2009), 137–138.
24. [24] Saito, R., Smoot, M.E., Ono, K., Ruscheinski, J., Wang, P.L., Lotia, S., Pico, A.R., Bader, G.D., Ideker, T., A travel guide to Cytoscape plugins. Nat. Methods 9 (2012), 1069–1076.
25. [25] Huang da, W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4 (2009), 44–57.
26. [26] Huang da, W., Sherman, B.T., Lempicki, R.A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37 (2009), 1–13.
27. [27] Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., Cerami, E., Sander, C., Schultz, N., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal, 6, 2013, pl1.
28. [28] Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A.P., Sander, C., Schultz, N., The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2 (2012), 401–404.
29. [29] Castelo-Branco, G., Wagner, J., Rodriguez, F.J., Kele, J., Sousa, K., Rawal, N., Pasolli, H.A., Fuchs, E., Kitajewski, J., Arenas, E., Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc. Natl. Acad. Sci. USA 100 (2003), 12747–12752.
30. [30] Habu, M., Koyama, H., Kishida, M., Kamino, M., Iijima, M., Fuchigami, T., Tokimura, H., Ueda, M., Tokudome, M., Koriyama, C., Hirano, H., Arita, K., Kishida, S., Ryk is essential for Wnt-5a-dependent invasiveness in human glioma. J. Biochem. 156 (2014), 29–38.
31. [31] Hirano, H., Yonezawa, H., Yunoue, S., Habu, M., Uchida, H., Yoshioka, T., Kishida, S., Kishida, M., Oyoshi, T., Fujio, S., Sugata, S., Yamahata, H., Hanaya, R., Arita, K., Immunoreactivity of Wnt5a, Fzd2, Fzd6, and Ryk in glioblastoma: evaluative methodology for DAB chromogenic immunostaining. Brain Tumor Pathol. 31 (2014), 85–93.
32. [32] Verhaak, R.G., Hoadley, K.A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M.D., Miller, C.R., Ding, L., Golub, T., Mesirov, J.P., Alexe, G., Lawrence, M., O'Kelly, M., Tamayo, P., Weir, B.A., Gabriel, S., Winckler, W., Gupta, S., Jakkula, L., Feiler, H.S., Hodgson, J.G., James, C.D., Sarkaria, J.N., Brennan, C., Kahn, A., Spellman, P.T., Wilson, R.K., Speed, T.P., Gray, J.W., Meyerson, M., Getz, G., Perou, C.M., Hayes, D.N., N. Cancer Genome Atlas Research, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17 (2010), 98–110.
33. [33] N. Cancer Genome Atlas Research, Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 (2008), 1061–1068.
34. [34] Bader, G.D., Hogue, C.W., An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform., 4, 2003, 2.
35. [35] Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstrale, M., Laurila, E., Houstis, N., Daly, M.J., Patterson, N., Mesirov, J.P., Golub, T.R., Tamayo, P., Spiegelman, B., Lander, E.S., Hirschhorn, J.N., Altshuler, D., Groop, L.C., PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 (2003), 267–273.
36. [36] Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., Mesirov, J.P., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005), 15545–15550.
37. [37] Gomez, G.G., Kruse, C.A., Mechanisms of malignant glioma immune resistance and sources of immunosuppression. Gene Ther. Mol. Biol. 10 (2006), 133–146.
38. [38] Waziri, A., Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg. Clin. North Am. 21 (2010), 31–42.
39. [39] Reardon, D.A., Freeman, G., Wu, C., Chiocca, E.A., Wucherpfennig, K.W., Wen, P.Y., Fritsch, E.F., Curry, W.T. Jr., Sampson, J.H., Dranoff, G., Immunotherapy advances for glioblastoma. Neuro-Oncology 16 (2014), 1441–1458.
40. [40] Komohara, Y., Ohnishi, K., Kuratsu, J., Takeya, M., Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 216 (2008), 15–24.
41. [41] Szulzewsky, F., Pelz, A., Feng, X., Synowitz, M., Markovic, D., Langmann, T., Holtman, I.R., Wang, X., Eggen, B.J., Boddeke, H.W., Hambardzumyan, D., Wolf, S.A., Kettenmann, H., Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. PLoS One, 10, 2015, e0116644.
42. [42] Hussain, S.F., Yang, D., Suki, D., Aldape, K., Grimm, E., Heimberger, A.B., The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-Oncology 8 (2006), 261–279.
43. [43] Prosniak, M., Harshyne, L.A., Andrews, D.W., Kenyon, L.C., Bedelbaeva, K., Apanasovich, T.V., Heber-Katz, E., Curtis, M.T., Cotzia, P., Hooper, D.C., Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 19 (2013), 3776–3786.
44. [44] Blumenthal, A., Ehlers, S., Lauber, J., Buer, J., Lange, C., Goldmann, T., Heine, H., Brandt, E., Reiling, N., The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108 (2006), 965–973.
45. [45] Pereira, C., Schaer, D.J., Bachli, E.B., Kurrer, M.O., Schoedon, G., Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arter. Thromb Vasc Biol. 28 (2008), 504–510.
46. [46] Schaale, K., Neumann, J., Schneider, D., Ehlers, S., Reiling, N., Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses. Eur. J. Cell Biol. 90 (2011), 553–559.
47. [47] Halleskog, C., Schulte, G., WNT-3A and WNT-5A counteract lipopolysaccharide-induced pro-inflammatory changes in mouse primary microglia. J. Neurochem. 125 (2013), 803–808.
48. [48] Halleskog, C., Dijksterhuis, J.P., Kilander, M.B., Becerril-Ortega, J., Villaescusa, J.C., Lindgren, E., Arenas, E., Schulte, G., Heterotrimeric G protein-dependent WNT-5A signaling to ERK1/2 mediates distinct aspects of microglia proinflammatory transformation. J. Neuroinflammation, 9, 2012, 111.
49. [49] Hanisch, U.K., Kettenmann, H., Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10 (2007), 1387–1394.
50. [50] Kettenmann, H., Hanisch, U.K., Noda, M., Verkhratsky, A., Physiology of microglia. Physiol. Rev. 91 (2011), 461–553.
51. [51] Hammarberg, C., Schulte, G., Fredholm, B.B., Evidence for functional adenosine A3 receptors in microglia cells. J. Neurochem. 86 (2003), 1051–1054.
52. [52] Watkins, S., Robel, S., Kimbrough, I.F., Robert, S.M., Ellis-Davies, G., Sontheimer, H., Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells. Nat. Commun., 5, 2014, 4196.
53. [53] Yang, I., Han, S.J., Kaur, G., Crane, C., Parsa, A.T., The role of microglia in central nervous system immunity and glioma immunology. J. Clin. Neurosci.: Off. J. Neurosurg. Soc. Australas 17 (2010), 6–10.
54. [54] Ritchie, M.E., Phipson, B., Wu, D., Hu, Y., Law, C.W., Shi, W., Smyth, G.K., limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 2015.
55. [55] Deininger, M.H., Pater, S., Strik, H., Meyermann, R., Macrophage/microglial cell subpopulations in glioblastoma multiforme relapses are differentially altered by radiochemotherapy. J. Neuro-Oncol. 55 (2001), 141–147.
56. [56] Roggendorf, W., Strupp, S., Paulus, W., Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol. 92 (1996), 288–293.